It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The ATR-CHK1 DNA damage response pathway becomes activated by the exposure of RPA-coated single-stranded DNA (ssDNA) that forms as an intermediate during DNA damage and repair, and as a part of the replication stress response. Here, we identify ZNF827 as a component of the ATR-CHK1 kinase pathway. We demonstrate that ZNF827 is a ssDNA binding protein that associates with RPA through concurrent binding to ssDNA intermediates. These interactions are dependent on two clusters of C2H2 zinc finger motifs within ZNF827. We find that ZNF827 accumulates at stalled forks and DNA damage sites, where it activates ATR and promotes the engagement of homologous recombination-mediated DNA repair. Additionally, we demonstrate that ZNF827 depletion inhibits replication initiation and sensitizes cancer cells to the topoisomerase inhibitor topotecan, revealing ZNF827 as a therapeutic target within the DNA damage response pathway.
Here, the authors characterise the zinc finger protein ZNF827 as a single stranded DNA binding protein that accumulates at stalled replication forks to activate the ATR-CHK1 pathway and engage homologous-recombination mediated DNA repair.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details







1 University of Sydney, Telomere Length Regulation Unit, Children’s Medical Research Institute, Faculty of Medicine and Health, Westmead, Australia (GRID:grid.1013.3) (ISNI:0000 0004 1936 834X)
2 University of Sydney, Nuclear Dynamics Group, Children’s Medical Research Institute, Faculty of Medicine and Health, Westmead, Australia (GRID:grid.1013.3) (ISNI:0000 0004 1936 834X)
3 St Vincent’s Institute, Genome Stability Unit, Fitzroy, Australia (GRID:grid.1073.5) (ISNI:0000 0004 0626 201X)
4 University of Sydney, School of Life and Environmental Sciences, Sydney, Australia (GRID:grid.1013.3) (ISNI:0000 0004 1936 834X)
5 St Vincent’s Institute, Genome Stability Unit, Fitzroy, Australia (GRID:grid.1073.5) (ISNI:0000 0004 0626 201X); University of Melbourne, Department of Medicine (St Vincent’s), Fitzroy, Australia (GRID:grid.1008.9) (ISNI:0000 0001 2179 088X)
6 University of Sydney, Genome Integrity Unit, Children’s Medical Research Institute, Faculty of Medicine and Health, Westmead, Australia (GRID:grid.1013.3) (ISNI:0000 0004 1936 834X)